Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Blood (2016) 128 (22): 4010.

https://doi.org/10.1182/blood.V128.22.4010.4010

Published: 2016

Journal Articles

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

Blood (2016) 128 (22): 5871.

https://doi.org/10.1182/blood.V128.22.5871.5871

Published: 2016

Journal Articles

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Feras Alfraih, MD, Amjad Alhussaini, Farhan Anjum, Ghuzayel Mubarak Aldawsari, Fahad Alsharif, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Syed Osman Ahmed, MRCP, FRCPath, Amr Hanbali, MD, Marwan Shaheen, MD, Riad O. El Fakih, MD, Hazza A Alzahrani, MD, Naeem A. Chaudhri, MD FACP, Fahad Almohareb, Mahmoud Aljurf, MD MPH

Blood (2016) 128 (22): 5759.

https://doi.org/10.1182/blood.V128.22.5759.5759

Published: 2016

Journal Articles

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

Syed Osman Ahmed, MRCP, FRCPath, Amna Gamil, MD, Muhamad Hitham Almahayni, MD MRCP,, Naeem A. Chaudhri, MD FACP, Fahad Alsharif, MD, Said Y Mohamad, MD, Hazza A Alzahrani, MD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Shad Ahmed, MD, Khaled Ibrahim, Fahed Almhareb, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 5482.

https://doi.org/10.1182/blood.V126.23.5482.5482

Published: 2015

Journal Articles

Multiple Brain Hemorrhages on Presentation in a Patient with Accelerated Phase Chronic Myeloid Leukemia and Subsequent CNS Blast Crisis Despite Systemic Complete Molecular Response: Possible Role of CNS Bleed in Leukemia Proliferation

Aleem Aamer, MBBS, FRCP, FRCPath, Fatmah Al Wusibai, MBBS, Khalid AlSaleh, MBBS, FRCPC, MRCP, Fatma Alqahtani, MBBS, KSU fellowship, Zafar Iqbal, PhD, Naeem A. Chaudhri, MD FACP, Abdul Kareem M Al-Momen, MD FRCPC

Blood (2015) 126 (23): 5153.

https://doi.org/10.1182/blood.V126.23.5153.5153

Published: 2015

Journal Articles

CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients

Feras Alfraih, MD, Abdul Mannnan, Dennis Dong Hwan Kim, MD PhD, Ghuzayel Aldawsari, MD, Fahad Z. Alsharif, MBChB, MD, Hazza A Alzahrani, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Fahad Al Mohareb, MD, Mahmoud Aljurf, MD MPH, Naeem A. Chaudhri, MD FACP

Blood (2015) 126 (23): 3728.

https://doi.org/10.1182/blood.V126.23.3728.3728

Published: 2015

Journal Articles

Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients

Feras Alfraih, MD, Shad Ahmed, MD, Dennis Dong Hwan Kim, MD PhD, Walid Rasheed, MD, Ghuzayel Aldawsari, MD, Fahad Alsharif, MD, Said Y Mohamed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Naeem A. Chaudhri, MD FACP, Fahad Al Mohareb, MD, Mahmoud Al-Jurf, MD, Hazza A Alzahrani, MD

Blood (2015) 126 (23): 4783.

https://doi.org/10.1182/blood.V126.23.4783.4783

Published: 2015

Journal Articles

Improved Molecular Diagnosis of Aplastic Anemia/Bone Marrow Failure Syndromes Using a Novel Comprehensive Next Generation Sequencing Gene Panel

Majed Dasouki, MD, DABMG, Syed Osman Ahmed, MRCP, FRCPath, Ali Alahmari, MD, Amal Jabr, BSc, Moheeb Ali Alawwami, MSc, PhD, Naeem A. Chaudhri, MD FACP, AlMohareb Fahad, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Hazza A Alzahrani, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 4790.

https://doi.org/10.1182/blood.V126.23.4790.4790

Published: 2015

Journal Articles

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Ayodele Alaiya, MPH,MBBS,PhD FRCPath, Hazza A Alzahrani, MD, Zakia Shinwari, MSc, Tarek Owaidah, MD FRCPA, Fahad Al Mohareb, MD, Fahad Al Sharif, MD, Randa Al Nounou, MD, Naeem A. Chaudhri, MD FACP, Ghuzayel Aldawsari, MD, Amr Hanbali, MD, Marwan Shaheen, MD, Feras Alfraih, MD, Syed Osman Ahmed, MD MRCP, FRCPath, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 2414.

https://doi.org/10.1182/blood.V126.23.2414.2414

Published: 2015

Journal Articles

Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients

Feras Alfraih, MD, Wahiba Chebbo, Dennis Dong Hwan Kim, MD PhD, Ghuzayel Aldawsari, MD, Fahad Z. Alsharif, MBChB, MD, Hazza A Alzahrani, MD, Said Y Mohamed, MD, Walid Rasheed, MD, Amr Hanbali, MD, Syed Osman Ahmed, MRCP, FRCPath, Marwan Shaheen, MD, Naeem A. Chaudhri, MD FACP, Fahad Al Mohareb, MD, Mahmoud Aljurf, MD MPH

Blood (2015) 126 (23): 4387.

https://doi.org/10.1182/blood.V126.23.4387.4387

Published: 2015

Journal Articles

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Ayodele Alaiya, MD MPH, PhD, Naeem A. Chaudhri, MD FACP, Hafiz Malhan, MD, Tarek Owaidah, MD FRCPA, Zakia Shinwari, MSc, Jonathan Fox, PhD, Fahad Alsharif, MD, Said Mohamed, MD, Walid Rasheed, MD, Osman Ahmed Syed, MD FRCPA, Mahmoud D. Aljurf, MD

Blood (2014) 124 (21): 4556.

https://doi.org/10.1182/blood.V124.21.4556.4556

Published: 2014

Journal Articles

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4880.

https://doi.org/10.1182/blood.V118.21.4880.4880

Published: 2011

Journal Articles

FLT3 Internal Tandem Duplication and Kinase Domain Mutations Remain Poor Prognostic Markers in Intermediate Cytogenetic AML After Treatment with Transplant in First Remission

Mahmoud Aljurf, M.D., Hala Abalkhail, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Mohammed Toulimat, MT, Hazzaa Al Zahrani, M.D., Salem Khalil, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4627.

https://doi.org/10.1182/blood.V118.21.4627.4627

Published: 2011

Journal Articles

Validation of Proposed European Leukemia Net Recommendations for Standardized Reporting and Classification of Cytogenetic Risk in AML Patients Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Wahiba Chebbo, M.D., Shad Ahmed, M.D., Fazal Hussain, M.D., Tusneem Elhassan, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4894.

https://doi.org/10.1182/blood.V118.21.4894.4894

Published: 2011

Journal Articles

Dominance of Non-CLL Phenotype of Monoclonal B-Cell Lymphocytosis (MBL) in the Middle East and An Overall MBL Prevalence Comparable to Western Countries

Maher Albitar, M.D., Faisal Rawas, MT, Randa Nounou, M.D., Nasir Bakshi, M.D., Fahed Almhareb, M.D., Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Salem Khalil, M.D., Fahad Alsharif, M.D., Naeem A. Chaudhri, MD, FACP, Hassan El-Solh, MD, Mahmoud Aljurf, M.D.

Blood (2011) 118 (21): 4586.

https://doi.org/10.1182/blood.V118.21.4586.4586

Published: 2011

Journal Articles

Trisomy 8 Remains An Intermediate Cytogenetic Risk Factor in Patients with Acute Myeloid Leukemia (AML) Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Mohammad Bakr, M.D., Khalid Ibrahim, M.D., Fazal Hussain, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4900.

https://doi.org/10.1182/blood.V118.21.4900.4900

Published: 2011

Journal Articles

Clinical Relevance of IDH1 and IDH2 Mutations and Single Nucleotide Polymorphism (SNP) rs11554137 in Patients with Acute Myeloid Leukemia Treated with Stem Cell Transplant in First Complete Remission

Hala Abalkhail, PhD, Naeem A. Chaudhri, MD, FACP, Claudia Ulrike Walter, PhD, Hazzaa Al Zahrani, M.D., Randa Nounou, M.D., Ola Altombakty, MT, Fahed Almhareb, MBBS, FACP, Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4643.

https://doi.org/10.1182/blood.V118.21.4643.4643

Published: 2011

Journal Articles

Rearrangements of 12p in Acute Myeloid Leukemia (AML) Remain a Significant Adverse Prognostic Marker When Patients Are Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Wahiba Chebbo, M.D., Khalid Ibrahim, M.D., Mohammad Bakr, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4464.

https://doi.org/10.1182/blood.V118.21.4464.4464

Published: 2011

Journal Articles

The t(9;11) Confers Good Prognosis in AML Patients Treated with Stem Cell Transplantation As Compared to Non-t(9;11) and Other Adverse-Risk Abnormalities

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Abu Jafar Saleh, M.D., Wahiba Chebbo, M.D., Ghada El Gohary, M.D., Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 2527.

https://doi.org/10.1182/blood.V118.21.2527.2527

Published: 2011

Journal Articles

Chimerism Analysis of Free Circulating DNA in the Prediction of Relapse in Patients with Acute Leukemia Treated with Stem Cell Transplantation,

Mahmoud Aljurf, M.D., Hala Abalkhail, PhD, Amal Alseraihy, M.D., Mouhab Ayas, Abdullah Al-Jefri, M.D., Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Claudia Ulrike Walter, PhD, Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Hassan El-Solh, MD, Maher Albitar, M.D.

Blood (2011) 118 (21): 3533.

https://doi.org/10.1182/blood.V118.21.3533.3533

Published: 2011

NARROW

Real-World Data Indicates That the Addition of Etoposide to Idarubicin and Cytarabine (3+7) Induction in Young Adults (<60 years) with AML Does Not Improve Survival or Remission Rates

Addition of ATG to Myeloablative Haplo Conditioning with Post-Transplantation Cyclophosphamide Might Decrease the Risk of Gvhd and TRM without Increasing the Risk of Relapse

BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation; Incidence and Risk Factors

Young Adult Patients with Post -HCT Relapse of AML May Benefit from Aggressive Salvage and 2 nd Cellular Therapy

Multiple Brain Hemorrhages on Presentation in a Patient with Accelerated Phase Chronic Myeloid Leukemia and Subsequent CNS Blast Crisis Despite Systemic Complete Molecular Response: Possible Role of CNS Bleed in Leukemia Proliferation

CD20 Expression Is Associated with Higher Risk of Early Relapse at 1 Year Following Chemotherapy Treatment for Adolescent and Adult Acute Lymphoblastic Leukemia Patients

Fertility Recovery Following Allogeneic Bone Marrow Transplantation in Aplastic Anemia; A Study of 157 Patients

Improved Molecular Diagnosis of Aplastic Anemia/Bone Marrow Failure Syndromes Using a Novel Comprehensive Next Generation Sequencing Gene Panel

Molecular Classification of Bone Marrow Failure Syndromes: Protein Signatures As Surrogate Biomarker for Accurate Diagnosis of Severe Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome and Paroxysmal Nocturnal Hemoglobinuria Patients

Influence of Matched Sibling Donor's Availability and Stem Cell Transplantation on Treatment Outcome for Acute Lymphoblastic Leukemia; Study on 294 Patients

Proteomics–Based Approach Predicts Molecular Response and Stratifies Responders to Tyrosine Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) Patients

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

FLT3 Internal Tandem Duplication and Kinase Domain Mutations Remain Poor Prognostic Markers in Intermediate Cytogenetic AML After Treatment with Transplant in First Remission

Validation of Proposed European Leukemia Net Recommendations for Standardized Reporting and Classification of Cytogenetic Risk in AML Patients Treated with Stem Cell Transplantation

Dominance of Non-CLL Phenotype of Monoclonal B-Cell Lymphocytosis (MBL) in the Middle East and An Overall MBL Prevalence Comparable to Western Countries

Trisomy 8 Remains An Intermediate Cytogenetic Risk Factor in Patients with Acute Myeloid Leukemia (AML) Treated with Stem Cell Transplantation

Clinical Relevance of IDH1 and IDH2 Mutations and Single Nucleotide Polymorphism (SNP) rs11554137 in Patients with Acute Myeloid Leukemia Treated with Stem Cell Transplant in First Complete Remission

Rearrangements of 12p in Acute Myeloid Leukemia (AML) Remain a Significant Adverse Prognostic Marker When Patients Are Treated with Stem Cell Transplantation

The t(9;11) Confers Good Prognosis in AML Patients Treated with Stem Cell Transplantation As Compared to Non-t(9;11) and Other Adverse-Risk Abnormalities

Chimerism Analysis of Free Circulating DNA in the Prediction of Relapse in Patients with Acute Leukemia Treated with Stem Cell Transplantation,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only